[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351741-105":59,"doc-detail-351741-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrated-metabolomics-and-transcriptomics-analysis-unveils-key-metabolic-pathways-and-potential-biomarkers-in-clear-cell-renal-cell-carcinoma","Integrated metabolomics and transcriptomics analysis unveils key metabolic pathways and potential biomarkers in clear cell renal cell carcinoma","","Clear cell renal cell carcinoma (ccRCC) is a leading renal malignancy with rising incidence and mortality, driving the need for accurate diagnostics, effective monitoring, and improved clinical management. Integrated transcriptomics and metabolomics were performed on paired cancerous and non-cancerous tissue samples from five patients undergoing radical nephrectomy to clarify molecular drivers. Ten shared KEGG metabolic pathways were identified, highlighting purine and glycerophospholipid metabolism. Metabolite–gene network correlations linked metabolites with key genes, and phospholipid enzymes emerged as potential therapeutic targets. The results support pathway inhibition for disrupting tumor membrane formation and signaling, informing early diagnosis and prognosis. Future validation in larger cohorts is required.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrated-metabolomics-and-transcriptomics-analysis-unveils-key-metabolic-pathways-and-potential-biomarkers-in-clear-cell-renal-cell-carcinoma/351741/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrated-metabolomics-and-transcriptomics-analysis-unveils-key-metabolic-pathways-and-potential-biomarkers-in-clear-cell-renal-cell-carcinoma/351741.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is identifying biomarkers for clear cell renal cell carcinoma (ccRCC) urgently needed?","Question",{"text":112,"@type":113},"ccRCC incidence and mortality are increasing, yet widely accepted tissue or blood biomarkers are not established for routine clinical use. This motivates better diagnostic and monitoring tools.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What approach did the study use to investigate ccRCC molecular mechanisms?",{"text":117,"@type":113},"The study integrated transcriptomics and metabolomics using paired cancerous and non-cancerous tissue samples from five patients who underwent radical nephrectomy.",{"name":119,"@type":110,"acceptedAnswer":120},"Which metabolic pathways and biomarker candidates were highlighted?",{"text":121,"@type":113},"Ten shared KEGG metabolic pathways were found, with purine metabolism and glycerophospholipid metabolism particularly relevant. Network analysis linked specific metabolites with key genes, and enzymes in phospholipid metabolism were proposed as potential therapeutic targets.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351741,1790198334,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Zhou et al. Discover Oncology (2026) 17:796 [https://doi.org/10.1007/s12672-026-04612-1](https://doi.org/10.1007/s12672-026-04612-1)  \nDiscover Oncology  \nRESEARCH Open Access  \nIntegrated metabolomics and transcriptomics analysis unveils key metabolic pathways and potential biomarkers in clear cell renal cell carcinoma  \nXiaoguang Zhou1†, Kunpeng Zhang2†, Zhendong Wang3, Lulu Yang2, Yongzhuo Zhang4* and Zhichao Xue3*  \n†Xiaoguang Zhou and Kunpeng Zhang have contributed equally to this work and should be considered co-first authors.  \n*Correspondence: Yongzhuo Zhang [zhangyz@nim.ac.cn](zhangyz@nim.ac.cn)[ ](zhangyz@nim.ac.cn)Zhichao Xue [xuezc@nim.ac.cn](xuezc@nim.ac.cn)  \n1Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, People’s Republic of China 2Technology Innovation Center of Mass Spectrometry for State Market Regulation, Center for Advanced Measurement Science, National Institute of Metrology,  \nBeijing  \n100029, People’s Republic of China 3School of Life Science and Engineering, Lanzhou University of Technology, Lanzhou  \n730050, People’s Republic of China 4Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, People’s Republic of China  \nAbstract  \nClear cell renal cell carcinoma (ccRCC) is the most prevalent histological subtype of renal cancer, with both incidence and mortality rates on the rise in recent years. This underscores the urgent need for precise diagnostic tools, effective monitoring, and improved management strategies. Advances in tumor sequencing have significantly enhanced our understanding of the molecular biology of ccRCC, leading to the identification of several potential genomic biomarkers. However, no widely accepted tissue or blood biomarker for ccRCC has been incorporated into routine clinical practice. In this study, we integrated transcriptomics and metabolomics analyses using paired cancerous and non-cancerous tissue samples from five patients who underwent radical nephrectomy. Our goal was to systematically investigate the molecular mechanisms underlying ccRCC and identify potential therapeutic targets. We identified ten shared KEGG metabolic pathways between the transcriptome and metabolome, with purine metabolism and glycerophospholipid metabolism emerging as particularly relevant to tumorigenesis and disease progression. Network analysis revealed significant correlations between specific metabolites (e. g., guanosine triphosphate and L-malic acid) and key genes (e. g., MET, SDHC, FH, and SDHB) within the molecular network of ccRCC. Additionally, we identified key enzymes in phospholipid metabolism, such as AK, LPCAT, and LPEAT, as potential therapeutic targets. Inhibiting these pathways could effectively disrupt tumor membrane formation and signal transduction. Our findings not only deepen the understanding of the molecular mechanisms driving ccRCC but also provide valuable insights for early diagnosis, prognosis evaluation, and the development of novel therapeutic strategies. Future work should focus on validating these potential biomarkers and therapeutic targets in larger cohorts and exploring their clinical utility.  \nKeywords Renal clear cell carcinoma, Transcriptomics, Metabolomics, Biomarker  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you","cbCailkXbY5ZYmMw","https://ap.wps.com/l/cbCailkXbY5ZYmMw","pdf",2246736,17,"English","# Abstract\n# Introduction","[{\"question\":\"Why is identifying biomarkers for clear cell renal cell carcinoma (ccRCC) urgently needed?\",\"answer\":\"ccRCC incidence and mortality are increasing, yet widely accepted tissue or blood biomarkers are not established for routine clinical use. This motivates better diagnostic and monitoring tools.\"},{\"question\":\"What approach did the study use to investigate ccRCC molecular mechanisms?\",\"answer\":\"The study integrated transcriptomics and metabolomics using paired cancerous and non-cancerous tissue samples from five patients who underwent radical nephrectomy.\"},{\"question\":\"Which metabolic pathways and biomarker candidates were highlighted?\",\"answer\":\"Ten shared KEGG metabolic pathways were found, with purine metabolism and glycerophospholipid metabolism particularly relevant. Network analysis linked specific metabolites with key genes, and enzymes in phospholipid metabolism were proposed as potential therapeutic targets.\"}]","Integrated metabolomics and transcriptomics analysis unveils key metabolic pathways and potential biomarkers in clear cell renal cell carcinoma | PDF",1790095606,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2586c0aec245cf50f886cb0a161aa7f2.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9981816330e63226727cc097d6b45919.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8dabc6a5631338a2fb14c641e2562eda.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51362d99c154a3c437e9b8a85ee64916.webp",980,1306]